Financial statements Aesthetic Pharma
Balance sheet data of AESTHETIC PHARMA
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|---|---|---|---|---|
Total assets | 249 632,94 | 238 919,86 | 271 023,38 | 373 807,41 | 391 385,31 |
A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
B. Current assets | 249 632,94 | 238 919,86 | 271 023,38 | 373 807,41 | 391 385,31 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 249 632,94 | 238 919,86 | 271 023,38 | 373 807,41 | 391 385,31 |
A. Equity | 32 583,96 | 37 845,37 | 50 552,33 | 124 893,34 | 128 587,56 |
B. Liabilities and provisions for liabilities | 217 048,98 | 201 074,49 | 220 471,05 | 248 914,07 | 262 797,75 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 217 048,98 | 201 074,49 | 220 471,05 | 248 914,07 | 262 797,75 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.